Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

PROVIDENCE, R.I. (AP) — A federal judge has ruled that the recent mass layoffs at the U.S. Health and Human Services were ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

The CDC, too, has stepped up its outreach to African American women, said Franciso Ruiz, team leader for national partnerships in the division of HIV/AIDS prevention. Its Pact to Act Against AIDS ...

The CDC recently published revised recommendations urging routine HIV screening in healthcare settings for individuals age 13 to 64, unless they opt out. This is not the first time that the CDC ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

In the USA, approximately 1.2 million are currently living with HIV, with disproportionate impact on racial/ethnic minorities and gay and bisexual men. 2 Although rates of new infections are ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they received 10 weeks ago that laid them off. Damage to their projects may ...